Author:
Lu Christine Y,Lupton Caitlin,Rakowsky Shana,Babar Zaheer-Ud-Din,Ross-Degnan Dennis,Wagner Anita K
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Tangcharoensathien V, Patcharanarumol W, Ir P, Aljunid S, Mukti A, Akkhavong K, et al. Health-financing reforms in Southeast Asia: challenges in achieving universal coverage. Lancet. 2011;377(9768):863–73.
2. World Health Organization: What is Universal Health Coverage? http://www.who.int/features/qa/universal_health_coverage/en/ . Accessed February 23, 2015.
3. Freemantle N, Hill S. Evaluating Pharmaceuticals for Health Policy and Reimbursement. Oxford, UK: Blackwell; 2004.
4. Lu CY, Williams K, Day R, March L, Sansom L, Bertouch J. Access to high cost drugs in Australia. BMJ. 2004;329(7463):415–6.
5. Walker S, Sculpher M, Claxton K, Palmer S. Coverage with evidence development, only in research, risk sharing, or patient access scheme? A framework for coverage decisions. Value Health. 2012;15(3):570–9.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献